Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

61.51 

-0.49 -0.8%

as of Dec 07 '18

52 Week Range:

54.09 97.38


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name May '08 May '09 May '10 May '11 May '12 May '13 May '14 May '15 May '16 May '17 May '18
Equity (BVPS) 2.42
2.82
3.23
4.05
4.63
5.10
5.95
6.80
7.74
8.87
10.47
growth rate 16.5% 14.5% 25.4% 14.3% 10.2% 16.7% 14.3% 13.8% 14.6% 18.0%
Earnings BIT 18.50
21.62
27.32
35.24
33.96
41.14
43.39
53.12
56.39
64.95
70.19
growth rate 16.9% 26.4% 29.0% -3.6% 21.1% 5.5% 22.4% 6.2% 15.2% 8.1%
Avg.PE 32.68
23.92
33.90
46.73
41.49
48.78
50.00
63.62
56.89
35.70
72.68
growth rate -26.8% 41.7% 37.9% -11.2% 17.6% 2.5% 27.2% -10.6% -37.3% 103.6%
ROA 10.45
10.33
10.87
11.42
9.55
10.03
8.86
9.09
8.67
8.94
11.02
growth rate -1.2% 5.2% 5.1% -16.4% 5.0% -11.7% 2.6% -4.6% 3.1% 23.3%
ROE 11.91
11.57
12.46
13.38
11.05
11.40
9.97
10.20
9.68
10.00
12.24
growth rate -2.9% 7.7% 7.4% -17.4% 3.2% -12.5% 2.3% -5.1% 3.3% 22.4%
ROIC 11.91
11.43
12.42
13.35
11.01
11.36
9.95
10.16
9.63
9.87
11.90
growth rate -4.0% 8.7% 7.5% -17.5% 3.2% -12.4% 2.1% -5.2% 2.5% 20.6%
Cur. Ratio 5.89
7.76
5.05
6.88
7.20
9.51
7.56
9.08
8.74
8.14
9.71
growth rate 31.8% -34.9% 36.2% 4.7% 32.1% -20.5% 20.1% -3.7% -6.9% 19.3%
Quick Ratio 3.02
4.02
2.95
4.76
5.22
7.00
5.14
6.81
6.13
5.89
7.49
growth rate 33.1% -26.6% 61.4% 9.7% 34.1% -26.6% 32.5% -10.0% -3.9% 27.2%
Leverage 1.14
1.10
1.18
1.16
1.15
1.13
1.13
1.12
1.12
1.12
1.10
growth rate -3.5% 7.3% -1.7% -0.9% -1.7% 0.0% -0.9% 0.0% 0.0% -1.8%
Balance Sheet May '08 May '09 May '10 May '11 May '12 May '13 May '14 May '15 May '16 May '17 May '18
Acct.Receivable 19.38
23.40
27.40
28.60
36.98
40.20
51.90
59.21
67.65
68.58
79.09
growth rate 20.7% 17.1% 4.4% 29.3% 8.7% 29.1% 14.1% 14.3% 1.4% 15.3%
Acct.Payable 19.98
17.72
13.40
13.69
15.80
16.24
20.75
growth rate -11.3% -24.4% 2.2% 15.4% 2.8% 27.7%
Cur.Assets 65.63
71.80
86.00
122.50
143.94
168.45
188.75
231.20
248.23
292.96
375.79
growth rate 9.4% 19.8% 42.4% 17.5% 17.0% 12.1% 22.5% 7.4% 18.0% 28.3%
Total Assets 126.36
142.20
180.20
219.70
251.60
290.56
345.30
392.18
449.94
528.41
618.01
growth rate 12.5% 26.7% 21.9% 14.5% 15.5% 18.8% 13.6% 14.7% 17.4% 17.0%
Cash 14.27
13.80
22.80
35.80
49.05
50.03
40.68
66.06
55.26
77.57
83.07
growth rate -3.3% 65.2% 57.0% 37.0% 2.0% -18.7% 62.4% -16.4% 40.4% 7.1%
Inventory 27.80
31.40
31.30
32.00
34.99
38.32
51.18
51.60
64.37
73.14
76.01
growth rate 13.0% -0.3% 2.2% 9.4% 9.5% 33.6% 0.8% 24.8% 13.6% 3.9%
Cur.Liabilities 11.14
9.20
17.00
17.80
19.98
17.72
24.97
25.46
28.60
36.00
38.69
growth rate -17.4% 84.8% 4.7% 12.2% -11.3% 40.9% 2.0% 12.3% 25.9% 7.5%
Liabilities 15.11
13.90
27.60
31.00
32.76
32.34
39.00
41.22
45.78
56.65
57.83
growth rate -8.0% 98.6% 12.3% 5.7% -1.3% 20.6% 5.7% 11.1% 23.8% 2.1%
LT Debt 0.00 0.00 0.00 0.00 0.00
growth rate
Equity 111.25
128.30
152.70
188.60
218.84
258.22
306.36
350.97
404.20
471.61
560.18
growth rate 15.3% 19.0% 23.5% 16.0% 18.0% 18.6% 14.6% 15.2% 16.7% 18.8%
Common Shares 45.00
45.00
46.00
48.00
48.00
49.00
50.00
50.00
51.00
51.00
52.00
growth rate 0.0% 2.2% 4.4% 0.0% 2.1% 2.0% 0.0% 2.0% 0.0% 2.0%
Cash Flow Statement May '08 May '09 May '10 May '11 May '12 May '13 May '14 May '15 May '16 May '17 May '18
Capital Expenditures 2.47
2.80
5.40
7.80
12.41
8.90
11.54
9.62
14.22
14.58
20.95
growth rate 13.4% 92.9% 44.4% 59.1% -28.3% 29.7% -16.7% 47.9% 2.5% 43.7%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 7.87
11.00
28.00
28.80
22.28
26.56
21.67
43.79
35.33
60.27
69.13
growth rate 39.8% 154.6% 2.9% -22.7% 19.2% -18.4% 102.1% -19.3% 70.6% 14.7%
FCF per Share 0.20
0.12
0.50
0.44
0.21
0.42
0.30
0.54
0.48
0.71
0.85
growth rate -40.0% 316.7% -12.0% -52.3% 100.0% -28.6% 80.0% -11.1% 47.9% 19.7%
Sale Purchase of Stock 5.80
9.53
14.85
8.56
12.36
21.15
23.26
growth rate 64.5% 55.8% -42.4% 44.5% 71.1% 10.0%
FCF 5.00
8.00
23.00
21.00
10.00
18.00
10.00
34.00
21.00
46.00
48.00
growth rate 60.0% 187.5% -8.7% -52.4% 80.0% -44.4% 240.0% -38.2% 119.1% 4.4%
Income Statement May '08 May '09 May '10 May '11 May '12 May '13 May '14 May '15 May '16 May '17 May '18
Sales 102.42
118.70
140.50
172.70
184.05
207.53
247.41
283.07
321.28
361.59
402.25
growth rate 15.9% 18.4% 22.9% 6.6% 12.8% 19.2% 14.4% 13.5% 12.6% 11.2%
Op.Income 18.02
20.50
26.90
35.80
22.51
27.19
43.39
53.12
56.39
64.95
70.19
growth rate 13.8% 31.2% 33.1% -37.1% 20.8% 59.6% 22.4% 6.2% 15.2% 8.1%
IBT 18.50
21.60
27.30
35.20
33.84
41.14
43.03
52.08
55.51
66.67
73.47
growth rate 16.8% 26.4% 28.9% -3.9% 21.6% 4.6% 21.0% 6.6% 20.1% 10.2%
Net Income 12.10
13.90
17.50
22.80
22.51
27.19
28.16
33.53
36.56
43.79
63.15
growth rate 14.9% 25.9% 30.3% -1.3% 20.8% 3.6% 19.1% 9.1% 19.8% 44.2%
EPS 0.27
0.30
0.38
0.48
0.47
0.56
0.57
0.68
0.72
0.86
1.21
growth rate 11.1% 26.7% 26.3% -2.1% 19.2% 1.8% 19.3% 5.9% 19.4% 40.7%
Gross Profit 53.23
59.40
73.00
87.80
92.43
109.49
122.60
139.69
153.06
171.97
190.25
growth rate 11.6% 22.9% 20.3% 5.3% 18.5% 12.0% 13.9% 9.6% 12.4% 10.6%
R&D 4.60
6.30
6.80
6.64
7.78
8.33
9.58
9.89
10.39
10.86
growth rate 37.0% 7.9% -2.4% 17.3% 7.0% 15.0% 3.3% 5.0% 4.5%

Quarterly Statements

Item Name Aug '17 Nov '17 Feb '18 May '18 Aug '18
Earnings BIT 16.42
18.00
15.91
19.86
16.48
growth rate 9.6% -11.6% 24.8% -17.0%
Balance Sheet Aug '17 Nov '17 Feb '18 May '18 Aug '18
Acct.Receivable 66.34
74.86
73.21
79.09
78.08
growth rate 12.8% -2.2% 8.0% -1.3%
Acct.Payable 16.67
17.43
19.65
20.75
20.89
growth rate 4.6% 12.8% 5.6% 0.7%
Cur.Assets 310.93
339.94
352.20
375.79
396.12
growth rate 9.3% 3.6% 6.7% 5.4%
Total Assets 547.33
581.03
595.60
618.01
640.93
growth rate 6.2% 2.5% 3.8% 3.7%
Cash 58.46
64.43
82.07
83.07
97.23
growth rate 10.2% 27.4% 1.2% 17.0%
Inventory 73.41
73.71
77.51
76.01
78.77
growth rate 0.4% 5.2% -1.9% 3.6%
Cur.Liabilities 38.32
37.95
37.29
38.69
39.22
growth rate -1.0% -1.7% 3.7% 1.4%
Liabilities 60.08
60.38
53.67
57.83
59.30
growth rate 0.5% -11.1% 7.8% 2.5%
LT Debt
growth rate
Equity 487.02
520.36
541.66
560.18
581.63
growth rate 6.9% 4.1% 3.4% 3.8%
Common Shares 6.12
8.24
8.25
8.28
8.32
growth rate 34.7% 0.2% 0.3% 0.5%
Cash Flow Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Capital Expenditures 4.42
5.99
5.89
4.65
1.92
growth rate 35.8% -1.8% -21.0% -58.7%
Cash From OA 18.67
8.74
19.17
22.56
16.08
growth rate -53.2% 119.4% 17.7% -28.7%
Sale Purchase of Stock 1.96
14.44
2.52
4.35
growth rate 638.2% -82.5% 72.4%
FCF 14.26
2.74
13.28
17.91
14.16
growth rate -80.8% 384.4% 34.8% -20.9%
Income Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Sales 95.26
101.82
95.89
109.29
99.63
growth rate 6.9% -5.8% 14.0% -8.8%
Op.Income 16.42
18.00
15.91
19.86
16.48
growth rate 9.6% -11.6% 24.8% -17.0%
IBT 17.24
19.05
17.28
19.90
17.14
growth rate 10.5% -9.3% 15.1% -13.9%
Net Income 11.91
17.10
16.59
17.55
15.24
growth rate 43.5% -3.0% 5.8% -13.2%
EPS
growth rate
Gross Profit 45.87
49.27
45.52
49.59
46.73
growth rate 7.4% -7.6% 8.9% -5.8%
R&D 3.10
2.97
2.84
1.95
2.82
growth rate -4.2% -4.4% -31.1% 44.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (96.85)

YOY Growth Grade:

B (72.47)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 48.56 48.47 45.64
EPS / Growth 12.8% 1.27 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 17.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.0% 13.4% 13.4%
Future PE 20.00 40.31 40.31
Future EPS 3.29 4.45 4.45
Value Price
MOS %
16.27
-73.5%
44.31
-28.0%
44.31
-28.0%
MOS Price 8.14 22.15 22.15
IRT 17.70 15.17 15.17

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.